• Investing Ideas
  • /
  • U.S. Pharmaceuticals & Biotech Strong Balance Sheet with Growth Potential
Header cover image

U.S. Pharmaceuticals & Biotech Strong Balance Sheet with Growth Potential

Stocks with plenty of capacity to fund future growth

18 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
ILMNIlluminaUS$432.82-3.2%44.3%US$63.5bUS$461.18P/E82.6xE30.0%n/a
SGENSeagenUS$161.343.3%-12.8%US$29.4bUS$184.61P/E49.1xE70.2%n/a
ICLRICONUS$283.045.5%54.5%US$22.6bUS$248.17P/E62xE17.5%n/a
RGENRepligenUS$323.265.3%124.0%US$17.8bUS$268.75P/E177.8xE20.3%n/a
INCYIncyteUS$69.00-9.2%-20.3%US$15.2bUS$102.19P/E45.1xE36.1%n/a
EXELExelixisUS$20.35-1.8%-14.6%US$6.4bUS$31.69P/E68.2xE36.0%n/a
BPMCBlueprint MedicinesUS$106.610.6%21.1%US$6.2bUS$119.00P/E18.4xE56.2%n/a
SAGESage TherapeuticsUS$45.42-2.1%-25.3%US$2.7bUS$83.05P/E4xE25.7%n/a
AVIRAtea PharmaceuticalsUS$32.1422.5%n/aUS$2.7bUS$65.00P/E75.4xE58.4%n/a
CORTCorcept TherapeuticsUS$20.29-1.1%18.7%US$2.4bUS$25.25P/E24.1xE28.4%n/a
VCELVericelUS$49.20-4.8%169.1%US$2.3bUS$65.04P/E261.8xE60.8%n/a
AMRNAmarinUS$5.404.9%41.7%US$2.1bUS$10.33P/E494.5xE81.2%n/a
XNCRXencorUS$33.88-2.0%-10.3%US$2.0bUS$53.42P/E84xE26.4%n/a
VNDAVanda PharmaceuticalsUS$17.261.8%85.2%US$960.3mUS$24.00P/E29.6xE38.0%n/a
AMPHAmphastar PharmaceuticalsUS$18.711.9%3.8%US$898.7mUS$22.75P/E86xE81.7%n/a
CARACara TherapeuticsUS$15.934.5%23.1%US$797.9mUS$26.33P/E95.5xE85.9%n/a
XOMAXOMAUS$24.49-4.6%29.9%US$277.0mUS$44.67P/E49xE63.0%n/a
CSBRChampions OncologyUS$10.461.2%11.9%US$140.4mUS$15.67P/E1222xE143.4%n/a
Page 1 of 1